Tenderwize
Back to tender search

Open House Biologics Discount Agreement for Lutropin alfa / Follitropin alfa

Techniker Krankenkasse·Hamburg, Germany·Deadline May 30, 2027 · 282 days left·Open·Supplies
Sign up to saveOpen documents
Original notice title

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2025-09 - Lutropin alfa / Follitropin alfa (Wirkstoffkombination)

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

Portal submission is not allowed; contracts must be submitted by email with qualified electronic signature or by post...

Only pharmaceutical undertakings meeting the AMG and authorisation requirements may participate.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply-related Open House discount agreements for pharmaceutical products.
  • Product scope: Lutropin alfa / Follitropin alfa combination.
Show full summary

This is an Open House supply arrangement by Techniker Krankenkasse (with HEK and hkk listed as participating buyers) for pharmaceutical products, specifically the Lutropin alfa / Follitropin alfa combination. The contract is non-exclusive, with uniform terms and no individual negotiations. The term is up to 24 months from 2025-06-01 and ends no later than 2027-05-31. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. No contract value is stated.

Risks

Portal submission is not allowed; contracts must be submitted by email with qualified electronic signature or by post...

Only pharmaceutical undertakings meeting the AMG and authorisation requirements may participate.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of Section 4(18) AMG for the offered medicinal products.
  • Applicant must have its seat in the AMG territory, another EU Member State, or another EEA state.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal products or otherwise be entitled to place them on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Biologics Discount Agreement for Lutropin alfa / Follitropin alfa

Single lot covering discount agreements under Section 130a(8) SGB V for the Lutropin alfa / Follitropin alfa medicinal product combination. The notice states the arrangement is open to all suitable pharmaceutical companies meeting the stated conditions, with no exclusivity and no individual negotiation. Scope and eligibility details are in the participation and contract documents.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline May 30, 2027

Procurement Details

Publication date
22 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
262656-2025

Documents (1)

Procurement document 1

Similar tenders

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

France – Pharmaceutical products – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026

Aug 21

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9